Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 71,760 |
|
|||||
| News | - | ||||||
| Day High | 0.5799 | Low High |
|||||
| Day Low | 0.557 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| VBI Vaccines Inc | VBIV | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0015 | -0.26% | 0.5695 | 15:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.57 | 0.557 | 0.5799 | 0.5695 | 0.571 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 309 | 71,760 | US$ 0.5653925 | US$ 40,573 | - | 0.45 - 3.47 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:12:01 | 83 | US$ 0.5699 | USD |
VBI Vaccines Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 13.5M | 23.69M | - | 8.68M | -93.84M | -3.96 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
VBI Vaccines News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/16/2024 | 07:00 | Business Wire | VBI Vaccines Reports Full Year 2023 Financial Results |
| 4/11/2024 | 15:05 | Business Wire | VBI Vaccines Announces Closing of $2 Million Registered.. |
| 4/09/2024 | 13:45 | Business Wire | VBI Vaccines Announces $2 Million Registered Direct Offering.. |
| 4/03/2024 | 07:00 | Business Wire | VBI Vaccines Presents Encouraging Early Tumor Response Data.. |
| 4/02/2024 | 07:00 | Business Wire | VBI Vaccines Announces Expanded Strategic Partnership with.. |
| 2/14/2024 | 07:34 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/14/2024 | 06:00 | Business Wire | VBI Announces Agreement to Sell Manufacturing Capabilities,.. |
| 2/06/2024 | 15:23 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/23/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/11/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/26/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/12/2023 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VBIV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5936 | 0.61 | 0.531 | 0.5739612 | 209,723 | -0.0241 | -4.06% |
| 1 Month | 0.706 | 1.35 | 0.531 | 0.6785186 | 947,612 | -0.1365 | -19.33% |
| 3 Months | 0.62 | 1.35 | 0.53 | 0.6656509 | 489,247 | -0.0505 | -8.15% |
| 6 Months | 0.6047 | 1.35 | 0.52 | 0.6572246 | 289,107 | -0.0352 | -5.82% |
| 1 Year | 2.88 | 3.47 | 0.45 | 1.64 | 516,526 | -2.31 | -80.23% |
| 3 Years | 94.50 | 129.30 | 0.45 | 54.06 | 1,569,455 | -93.93 | -99.40% |
| 5 Years | 57.30 | 217.20 | 0.45 | 74.21 | 3,542,105 | -56.73 | -99.01% |
VBI Vaccines Description
| VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology. |
